GB1439625A - Compositions for reducing blood cholesterol - Google Patents

Compositions for reducing blood cholesterol

Info

Publication number
GB1439625A
GB1439625A GB4656473A GB4656473A GB1439625A GB 1439625 A GB1439625 A GB 1439625A GB 4656473 A GB4656473 A GB 4656473A GB 4656473 A GB4656473 A GB 4656473A GB 1439625 A GB1439625 A GB 1439625A
Authority
GB
United Kingdom
Prior art keywords
represents hydrogen
hydroxy
compositions
mixture
blood cholesterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4656473A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of GB1439625A publication Critical patent/GB1439625A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
GB4656473A 1972-10-06 1973-10-05 Compositions for reducing blood cholesterol Expired GB1439625A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA153,515A CA985172A (en) 1972-10-06 1972-10-06 Compositions and methods for reducing blood cholesterol

Publications (1)

Publication Number Publication Date
GB1439625A true GB1439625A (en) 1976-06-16

Family

ID=4094630

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4656473A Expired GB1439625A (en) 1972-10-06 1973-10-05 Compositions for reducing blood cholesterol

Country Status (16)

Country Link
US (1) US3890438A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU477269B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE805634A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA985172A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS197387B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD106948A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2348176A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES419355A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2201893B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1439625A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU169814B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE38274B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN138921B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7313519A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE403886B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA737246B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3838716A1 (de) * 1988-11-15 1990-05-17 Kanoldt Arzneimittel Gmbh Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie
US6929807B1 (en) * 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US20030118673A1 (en) * 1998-03-26 2003-06-26 Zongqin Xia Smilagenin and anzurogenin-D for the treatment of alzheimer's disease
CN1198622C (zh) * 1998-03-26 2005-04-27 植物药物公共有限公司 用于治疗阿尔茨海默病的甾类皂苷及其衍生物
GB2347676A (en) * 1999-03-08 2000-09-13 Phytopharm Plc Screening method
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
WO2003022287A1 (fr) * 2001-08-24 2003-03-20 Jilin Tianyao Science And Technology Co. Ltd. UTILISATION DE 3β-HYDROXY-5-SPIROSTENE POUR PREVENIR OU TRAITER DES MALADIES OU DES ETATS CARDIO-VASCULAIRES, INHIBER DES TUMEURS ET REDUIRE LES LIPIDES SANGUINS
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
CN102727501A (zh) * 2002-03-27 2012-10-17 菲特法姆股份有限公司 皂角苷配基及其衍生物的用途
AU2003231427A1 (en) * 2002-04-15 2003-10-27 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Compounds and preparation methods of carboxylate and monoester succinate derivative of diosgenin
GB0409567D0 (en) 2004-04-28 2004-06-02 Phytopharm Plc Chemical compounds
US20090209489A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions for the treatment of diabetis, system PH disorders, high blood pressure, and a cancer marker system
US20090209486A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions of carbohydrates as dietary supplements
US20090209488A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions for the treatment of exercise induced asthma
US20090208588A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown GERD carbohydrate compositions
WO2012010896A1 (en) 2010-07-20 2012-01-26 Phytopharm Plc Treatment of l-dopa, dopamine agonist and/or dopamine enhancer induced disorders
FR3133158A1 (fr) 2022-03-04 2023-09-08 Psa Automobiles Sa Procédé de gestion énergetique d’une prise d’alimentation d’accessoire dans un véhicule automobile à l’arrêt

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE630211A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1962-03-28

Also Published As

Publication number Publication date
BE805634A (fr) 1974-04-03
CA985172A (en) 1976-03-09
SE403886B (sv) 1978-09-11
IE38274L (en) 1974-04-06
FR2201893A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-05-03
HU169814B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-02-28
ES419355A1 (es) 1976-03-01
DD106948A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-07-12
FR2201893B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-09-09
DE2348176A1 (de) 1974-04-11
CS197387B1 (en) 1980-05-30
NL7313519A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-04-09
AU477269B2 (en) 1976-10-21
IN138921B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-04-17
US3890438A (en) 1975-06-17
ZA737246B (en) 1975-04-30
IE38274B1 (en) 1978-02-01
AU6110873A (en) 1975-04-10

Similar Documents

Publication Publication Date Title
GB1439625A (en) Compositions for reducing blood cholesterol
AU4703989A (en) Phosphinic acid substituted steroids as inhibitors of 5 alpha-reductase
IL88239A0 (en) Benzocycloheptene derivatives,their preparation and pharmaceutical compositions containing them
GB1171509A (en) Pyridine Derivatives
GB1413892A (en) 2-pyrimidinyl-thio-acetic acids and their derivatives
IE34511B1 (en) Heterocyclic ethers of-1-substituted-4-hydroxyalkyl piperazines and process for preparing them
GB1280752A (en) Phenoxycarboxylic acid derivatives, processes for producing them, and compositions containing them
GB1506823A (en) Prostaglandins
GB1256849A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB1207930A (en) Azacycloaliphatic compounds, process for their manufacture and compositions containing them
ES474785A1 (es) Un procedimiento para la preparacion de compuestos derivadosde 1-(naftiletil)imidazol
GB1381426A (en) Method of treating mammals and composition comprising oligosaccha ride sulphuric acid esters and nonionic surface active agents
GB1280386A (en) Anti-fertility agents
GB1152677A (en) Improved Anabolic Agent
GB1280244A (en) Serum triglyceride-lowering compositions
GB1298587A (en) Methods of contraception and contraceptive compositions
IE35873B1 (en) New sulphonic acid esters their preparation and their medicinal use
GB1173809A (en) N-Substituted Nor-Morphines
GB1410275A (en) Phenoxycarboxylic acid derivatives their preparation and compositions containing them
GB1299289A (en) Piperidine derivatives
IE39587B1 (en) Antibacterial compositions
GB1294530A (en) Spiroadamantanethiazepinones and derivatives thereof
GB1220793A (en) Pharmaceutical compositions
IE38206L (en) Ó-aminoalkyl-4-hydroxy-3-alkylsulphonylmethylbenzyl alcohols
GB1430188A (en) Diaza-oxa-bicyclodecane derivatives

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee